GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
90.29
+2.88 (3.29%)
At close: Aug 26, 2026, 4:00 PM EDT
89.00
-1.28 (-1.42%)
Pre-market: Aug 27, 2026, 4:44 AM EDT
GeneDx Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 443.99 | 416.67 | 302.16 | 195.65 | 227.33 | 205.1 |
Other Revenue | 10.43 | 10.87 | 3.29 | 6.91 | 7.36 | 7.1 |
| 454.43 | 427.54 | 305.45 | 202.57 | 234.69 | 212.2 | |
Revenue Growth | 25.42% | 39.97% | 50.79% | -13.69% | 10.60% | 18.33% |
Cost of Revenue | 139.13 | 129.36 | 111 | 112.42 | 261.44 | 228.8 |
Gross Profit | 315.3 | 298.18 | 194.45 | 90.15 | -26.75 | -16.6 |
Selling, General & Admin | 291.14 | 237.82 | 171.89 | 199.98 | 338.24 | 324.39 |
Research & Development | 83.83 | 72.03 | 45.72 | 58.27 | 86.2 | 105.16 |
Other Operating Expenses | - | - | - | 1.96 | 6.31 | - |
Operating Expenses | 374.97 | 309.85 | 217.61 | 260.2 | 430.76 | 429.55 |
Operating Income | -59.67 | -11.67 | -23.16 | -170.06 | -457.51 | -446.15 |
Interest Expense | -2.98 | -2.54 | -3.03 | - | -0.67 | -2.84 |
Interest & Investment Income | - | - | - | 1.11 | - | 0.08 |
Other Non Operating Income (Expenses) | 0.68 | -1.2 | -13.58 | 1.17 | 70.29 | 198.22 |
EBT Excluding Unusual Items | -61.97 | -15.42 | -39.78 | -167.77 | -387.89 | -250.69 |
Merger & Restructuring Charges | -1.45 | -1.41 | -0.05 | -0.14 | - | - |
Asset Writedown | -31.29 | - | - | -10.4 | -210.15 | - |
Legal Settlements | -4.8 | -4.8 | -12.8 | - | - | - |
Other Unusual Items | -6.78 | 0.48 | - | 1.62 | - | 5.3 |
Pretax Income | -106.3 | -21.14 | -52.63 | -176.69 | -598.03 | -245.39 |
Income Tax Expense | 0.06 | -0.12 | -0.34 | -0.93 | -49.05 | - |
Net Income | -106.36 | -21.02 | -52.29 | -175.77 | -548.98 | -245.39 |
Net Income to Common | -106.36 | -21.02 | -52.29 | -175.77 | -548.98 | -245.39 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 29 | 29 | 27 | 24 | 10 | 3 |
Shares Outstanding (Diluted) | 29 | 29 | 27 | 24 | 10 | 3 |
Shares Change | 2.38% | 6.51% | 10.61% | 137.49% | 212.57% | - |
EPS (Basic) | -3.64 | -0.73 | -1.94 | -7.23 | -53.63 | -74.93 |
EPS (Diluted) | -3.64 | -0.73 | -1.94 | -7.23 | -53.63 | -74.93 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -75.8 | 14.26 | -33.99 | -185.4 | -326.31 | -199.83 |
Free Cash Flow Per Share | -2.59 | 0.50 | -1.26 | -7.63 | -31.88 | -61.02 |
Gross Margin | 69.38% | 69.74% | 63.66% | 44.50% | -11.40% | -7.82% |
Operating Margin | -13.13% | -2.73% | -7.58% | -83.95% | -194.94% | -210.25% |
Profit Margin | -23.41% | -4.92% | -17.12% | -86.77% | -233.91% | -115.64% |
Free Cash Flow Margin | -16.68% | 3.34% | -11.13% | -91.52% | -139.04% | -94.17% |
EBITDA | -33.7 | 12.65 | -2.11 | -142.92 | -413.6 | -429.94 |
EBITDA Margin | -7.41% | 2.96% | -0.69% | -70.56% | -176.23% | -202.62% |
D&A For EBITDA | 25.98 | 24.32 | 21.05 | 27.13 | 43.91 | 16.21 |
EBIT | -59.67 | -11.67 | -23.16 | -170.06 | -457.51 | -446.15 |
EBIT Margin | -13.13% | -2.73% | -7.58% | -83.95% | -194.94% | -210.25% |
Revenue as Reported | 454.43 | 427.54 | 305.45 | 202.57 | 234.69 | 212.2 |